Public fear of COVID-19 vaccines in Iraqi Kurdistan region: a cross-sectional study

Background Vaccines remain one of the most effective methods to control infectious diseases; however, COVID-19 vaccines are challenging and novel. Vaccine support is still substantial in general, although vaccination fear has increased dramatically in recent decades. This is the first study aimed to determine the fear of the COVID-19 vaccination and the role of factors and reasons associated with fear in the Iraqi Kurdistan region. Results A total of 1188 participants responded to the questionnaire about their fears of the COVID-19 vaccine. The majority of participants had a medium level of fear (56.7%). Fear was significantly ( p < 0.001) associated with major demographic characteristics, social media use (51.8%), and losing family members, while other variables (previous seasonal influenza vaccine, previous infection, chronic medical diseases) show no relationship. Fear of side effects such as blood clotting was reported by the majority (45.03%) and indicated positive relation ( p < 0.016). On the other hand, a high proportion, 39.9% and 34.01%, were afraid of AstraZeneca and Pfizer ( p < 0.001), respectively; however, only about 4.63% had fear of Sinopharm. Conclusions The fear of COVID-19 vaccination was widespread in the Iraqi Kurdistan region. In this way, fear was related to significant variables. To reduce the fear of vaccines and increase public acceptance, authorities and the Ministry of Health should initiate a public awareness campaign. As a result, the public health crisis will significantly improve.